The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D

被引:13
|
作者
Hawton, A. [1 ]
Green, C. [1 ]
Telford, C. J. [1 ]
Wright, D. E. [2 ]
Zajicek, J. P. [3 ]
机构
[1] Univ Exeter, Hlth Econ Grp, PenCLAHRC, Peninsula Coll Med & Dent, Exeter EX2 4SG, Devon, England
[2] Univ Plymouth, Ctr Hlth & Environm Stat, Plymouth PL4 8AA, Devon, England
[3] Univ Plymouth, Clin Neurol Res Grp, Peninsula Coll Med & Dent, Plymouth PL4 8AA, Devon, England
关键词
cost effectiveness; decision making; multiple sclerosis; outcomes research; quality of life; walking; DISEASE QUESTIONNAIRE; PATIENT; IMPACT; QUALITY; INDEX; LIFE; IMPAIRMENT; DISABILITY; MOBILITY; UTILITY;
D O I
10.1177/1352458511429319
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Walking impairment has a major influence on the quality of life of people with multiple sclerosis (MS). The Multiple Sclerosis Walking Scale (MSWS-12) assesses the impact of MS on walking ability from the patient's perspective, but in its current form, is not amenable for use in many policy decision-making settings. Objectives: Statistical 'mapping' methods were used to convert MSWS-12 scores to EQ-5D health state values. Methods: The relationship between the measures was estimated using cohort data from people with MS in South West England. Regression analyses were conducted, estimation errors assessed, and predictive performance of the best models tested using longitudinal data. Results: Model performance was in line with that of other mapping studies, with the best-performing models being an ordinary least squares (OLS) model using MSWS-12 item scores, and an OLS model using the total MSWS-12 score and its squared term. Conclusions: A process has been described whereby data from a patient-reported outcome measure (MSWS-12) can be converted to (EQ-5D) health state values. These values may be used to consider the health-related quality of life of people with MS, to estimate quality adjusted life-years for use in effectiveness and cost-effectiveness analyses, and to inform health policy decisions.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 28 条
  • [1] Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients
    Limone, Brendan L.
    Sidovar, Matthew F.
    Coleman, Craig I.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [2] Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients
    Brendan L Limone
    Matthew F Sidovar
    Craig I Coleman
    Health and Quality of Life Outcomes, 11
  • [3] ESTIMATION OF THE EFFECT OF DALFAMPRIDINE EXTENDED RELEASE ON HEALTH UTILITY IN PATIENTS WITH MULTIPLE SCLEROSIS USING TWO EQUATIONS FOR MAPPING THE MSWS-12 TO THE EQ-5D
    Limone, B.
    Sidovar, M.
    Gaebler, J. A.
    Lee, S.
    Coleman, C., I
    VALUE IN HEALTH, 2012, 15 (07) : A554 - A555
  • [4] Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort
    Sidovar, Matthew F.
    Limone, Brendan L.
    Coleman, Craig I.
    PATIENT-RELATED OUTCOME MEASURES, 2016, 7 : 13 - 18
  • [5] Evaluation of the effect of dalfampridine-ER on the EQ-5D based on an MSWS-12 to EQ-5D mapping equation derived in North American patients
    Sidovar, M.
    Limone, B.
    Gaebler, J.
    Lee, S.
    Coleman, C.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 255 - 255
  • [6] EuroQol EQ-5D and condition-specific measures of health outcome in women with urinary incontinence: reliability, validity and responsiveness
    Kirstie L. Haywood
    Andrew M. Garratt
    Ranjit Lall
    Jan Fereday Smith
    Sarah E. Lamb
    Quality of Life Research, 2008, 17 : 475 - 483
  • [7] EuroQol EQ-5D and condition-specific measures of health outcome in women with urinary incontinence: reliability, validity and responsiveness
    Haywood, Kirstie L.
    Garratt, Andrew M.
    Lall, Ranjit
    Smith, Jan Fereday
    Lamb, Sarah E.
    QUALITY OF LIFE RESEARCH, 2008, 17 (03) : 475 - 483
  • [8] Measuring health-related quality of life in bipolar disorder: Relationship of the EuroQol (EQ-5D) to condition-specific measures
    Hayhurst, Hazel
    Palmer, Stephen
    Abbott, Rosemary
    Johnson, Tony
    Scott, Jan
    QUALITY OF LIFE RESEARCH, 2006, 15 (07) : 1271 - 1280
  • [9] Measuring health-related quality of life in bipolar disorder: Relationship of the EuroQol (EQ-5D) to condition-specific measures
    Hazel Hayhurst
    Stephen Palmer
    Rosemary Abbott
    Tony Johnson
    Jan Scott
    Quality of Life Research, 2006, 15 : 1271 - 1280
  • [10] Mapping health outcome measures from a stroke registry to EQ-5D weights
    Ghatnekar, Ola
    Eriksson, Marie
    Glader, Eva-Lotta
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11